Webinar
MIDAS Early Bird: Uncovering the defining trends of 2023 and what these hold for 2024
calendar

March 14, 2024

Calendar
clock

2:30pm - 3:30pm

(GMT+01:00)

Register

View all IQVIA events

As the healthcare landscape continues to evolve, the pharmaceutical industry must adapt to the shifting dynamics that are shaping its future. From increased need for specialty treatments, to permanent change in HCP engagement preference, to the growing importance of patient voice, there have been numerous challenges for the industry in 2023. And despite these, the market grew in value by 11% last year.

Did you know that innovative biologics surged in value last year, with triple the growth of innovative small molecules?

Join us and get the answers, as we provide a first view of key pharma metrics for 2023, assess the current state of post-pandemic recovery, and give an outlook on what lies ahead in 2024.

In this webinar we will:

  • Examine recent launches relative to the historic benchmark
  • Look at the evolution of physician engagement through pre- to post-pandemic
  • Take a deep dive into the Oncology and Immunology therapy areas, including insights from MIDAS Disease
  • Assess the latest trends in the generics and biosimilars sectors
  • Review the transformational developments in the Diabetes and Obesity markets
Don’t miss the opportunity to refine your strategy for the coming years with the latest insights into global sales and volume trends. Register now!

Related solutions

Contact Us